Xilio Therapeutics, Inc. 是一家生物科技公司,致力設計免疫療法以改善癌症患者的免疫系統。公司總部位於馬薩諸塞州沃爾瑟姆。
財務指標
營業收入
2026-06-30
$18.69M
2026-03-31
$12.64M
2025-12-31
$13.68M
2025-09-30
$19.06M
營業支出
2026-06-30
$22.18M
2026-03-31
$26.41M
2025-12-31
$25.52M
2025-09-30
$20.99M
淨利潤
2026-06-30
-$6.37M
2026-03-31
-$9.52M
2025-12-31
$10.36M
2025-09-30
-$16.28M
淨利潤率
2026-06-30
-34.09%
2026-03-31
-75.34%
2025-12-31
75.69%
2025-09-30
-85.42%
每股收益
2026-06-30
$-0.33
2026-03-31
$-0.58
2025-12-31
$0.80
2025-09-30
$-1.54
息稅折舊攤銷前利潤
2026-06-30
-$6.04M
2026-03-31
-$9.18M
2025-12-31
$10.68M
2025-09-30
-$15.94M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$18.69M
$12.64M
$13.68M
$19.06M
營業支出
$22.18M
$26.41M
$25.52M
$20.99M
淨利潤
-$6.37M
-$9.52M
$10.36M
-$16.28M
淨利潤率
-34.09%
-75.34%
75.69%
-85.42%
每股收益
$-0.33
$-0.58
$0.80
$-1.54
息稅折舊攤銷前利潤
-$6.04M
-$9.18M
$10.68M
-$15.94M
有效稅率
--
--
--
--
常見問題
XLO stock represents ownership shares in Xcelerate Solutions Inc., a company that provides cybersecurity, intelligence, and mission-support services to U.S. government agencies. The ticker XLO trades on the Nasdaq Capital Market. The company generates revenue primarily through federal contracts, with operations spanning cybersecurity, analytics, and technology integration. Because XLO operates in the government services sector, its performance is closely tied to federal spending priorities and contract awards.
Recent performance data for XLO, including daily price changes and trading volume, can be found in the price chart and performance section of this page. Share prices can fluctuate based on contract wins, earnings reports, and broader market conditions. For the most current XLO price movement and recent trends, please refer to the latest data displayed above.
Evaluating XLO's valuation involves comparing its market price to fundamental metrics such as earnings, revenue, and book value. Common tools include the price-to-earnings ratio, price-to-sales ratio, and enterprise value-to-EBITDA. Investors may also compare these multiples to peers in the government technology and cybersecurity sector. Because XLO operates in a contract-driven industry, its valuation can be influenced by backlog, margins, and contract renewals. The latest valuation ratios for XLO are available on this page.
XLO shares can be traded during regular U.S. market hours, typically 9:30 a.m. to 4:00 p.m. Eastern Time on weekdays. Many brokers also offer pre-market and after-hours trading sessions, though liquidity and price spreads may be less favorable. XLO is listed on the Nasdaq Capital Market. Investors should check with their brokerage for specific trading hours and any extended-hours availability for XLO.
XLO does not currently pay dividends. The company retains its earnings to fund operations, growth initiatives, or debt obligations. For investors seeking income, XLO may not be suitable. To confirm whether XLO's dividend policy has changed, please check the dividend section on this page or the company's investor relations website for the latest updates.
Key risks for XLO include reliance on U.S. government contracts, which can be affected by budget changes, delays, or policy shifts. The company faces competition from larger government services firms, and its financial performance may be sensitive to contract concentrations. Additionally, XLO's relatively small market capitalization can lead to higher price volatility and lower trading liquidity. Changing economic conditions and interest rates can also impact government spending and the company's cost of capital.